TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: overall colonic transit at 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: stool frequency, consistency and ease of passage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction of pain and disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of fever
Endpoint domain: Adverse events/effects
Primary endpoint: bowel movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Bioequivalence of RMP formulation E
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of adjudicated PMI events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recurrent dysphagia
Endpoint domain: Adverse events/effects
Primary endpoint: mean sensitivity increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inadequate smear rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration of atorvastatin and rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean PAP (cm H(2)O)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abdominal circumference increase (cm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time of return to consciousness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of complete occlusion of the LAA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioequivalence based on pharmacokinetic parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vital signs stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Actuarial survival at 3 years
Endpoint domain: Mortality/survival
Primary endpoint: Histological complete response at surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported physical IPV
Endpoint domain: Adverse events/effects
Primary endpoint: LARC method use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IOP spike higher than 25 mm Hg
Endpoint domain: Adverse events/effects
Primary endpoint: OSDI scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: blood transfusion risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: hemoglobin concentration drop
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Pain reported during the 5 days after TM surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate increase after nicotine treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinically significant depression symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Depressive episode
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hopelessness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of hepatocellular carcinoma
Endpoint domain: Mortality/survival
Primary endpoint: general diet management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood glucose self-monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of hyperemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total AQ score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum vitamin C and beta-carotene levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Major infection
Endpoint domain: Adverse events/effects
Primary endpoint: perceived pain reduction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: perceived stress reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sputum total glutathione content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentrations of XN and metabolites (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ischemia time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Internal thoracic artery pedicle temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Flow of internal thoracic artery pedicle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficiency of topically applied papaverine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sigmoidoscopy scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mRNA levels for human beta defensins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Tumour necrosis factor alpha and interleukin 1alpha levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean Quigley & Hein plaque score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean bleeding upon marginal probing score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean percent reduction in plaque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCR positivity for spirochetemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-rater concordance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Day 90 mortality
Endpoint domain: Mortality/survival
Primary endpoint: Change in spinal BMD at month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in hip BMD at month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suppression of bone turnover markers (β‐CTX and P1NP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T2DM medication dose reduction
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: CFB for factor VII (FVII)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: CFB for plasminogen (PLG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: end‐of‐treatment FVII level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: TFBUT (Tear Film Break-Up Time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Active ankle stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proprioceptive acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tear Film Interference (TFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interocular difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to standing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: effective time to hospital discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: health-related quality of life outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Excellent intubating condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Burning or heat sensation
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Atrial Fibrillation Rate (AFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total-to-HDL cholesterol ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neuropsychiatric effects
Endpoint domain: Adverse events/effects
Primary endpoint: Infusion site reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Hyponatremia
Endpoint domain: Adverse events/effects
Primary endpoint: symptomatic reherniation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reoperation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients achieving the MCID without a reoperation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Retention of motor skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MODS, mortality and complication ratios
Endpoint domain: Mortality/survival
Primary endpoint: Acute physiology and chronic health evaluation II scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of abdominal pain extinct
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nasopharyngeal temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma insulin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Urinary level of 8-iso-PG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Superficial wound complication rates
Endpoint domain: Adverse events/effects
Primary endpoint: immediate postabortion visual analog scale pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: drape adhesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 2-hour pain relief response proportion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PVA scale score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worst pain intensity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of MPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance on the Hearing Aid Management test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of prompts required to perform tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time taken to perform tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of epistaxis
Endpoint domain: Adverse events/effects
Primary endpoint: Implementation of prioritised ergonomic measures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: invasive breast cancer event
Endpoint domain: Mortality/survival
Primary endpoint: Mean sitting diastolic blood pressure (SDBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean sitting systolic blood pressure (SSBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cumulative incidences of major flare
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidences of short-lived flares
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect of psychotherapy on patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: O2peak improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of clinical events
Endpoint domain: Adverse events/effects
Primary endpoint: mean compression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time until relapse of psoriasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: no pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subject acceptance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Aspiration rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: filtration success of primary glaucoma triple procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: implant stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of eosinophils in sputum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentration of IgM at the mucosal surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: self-reported violence perpetration
Endpoint domain: Adverse events/effects
Primary endpoint: dating abuse
Endpoint domain: Adverse events/effects
Primary endpoint: sexual harassment
Endpoint domain: Adverse events/effects
Primary endpoint: heart rate for 1 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decrease in MFI score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Decrease in HADS score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decrease in PSQI score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: PANSS positive score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PANSS negative score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FEV1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: FVC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Knowledge of breast cancer treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ease of use and understanding of the application
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Worry about treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Healthy blood lipid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean AUC(0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean AUC24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Triclosan plasma concentration at steady state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 60 s all-out exercise performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relapse to smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient-centred communication skills
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Mean contrast medium volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean contrast-enhanced attenuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean qualitative enhancement scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of contralateral transient ischemic attacks (TIAs)
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of contralateral strokes
Endpoint domain: Adverse events/effects
Primary endpoint: cumulative stroke-free survival rates at 5 years
Endpoint domain: Mortality/survival
Primary endpoint: time to chest tube removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of prolonged air leakage
Endpoint domain: Adverse events/effects
Primary endpoint: Recovery rate after 3 months of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lowering Blood Pressure (BP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: supplemental consumption of metamizol
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Biochemical improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biliary enrichment (% UDCA of total bile salts)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facility delivery rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Antenatal care (ANC) increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Postnatal care (PNC) increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Heart Failure (HF) incidence
Endpoint domain: Mortality/survival
Primary endpoint: relative uptake in the apex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: relative uptake in the apical segments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: defects in the regions mentioned
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean times to union
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean limb shortening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional hip score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: FM pain composite responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average pain levels during treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median maximum pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of coughs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: airway symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: eye symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OMAS (Overall Mobility Assessment Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return to sports
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Hot flashes score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MENQOL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: number of throws per set
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total number of throws
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lactate response to exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: drinking water quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: child diarrhea
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Blood Glucose (MBG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Standard Deviation of Blood Glucose (SDBG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Amplitude of Glycemic Excursion (MAGE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Th2 cytokine production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ESR or CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ulnar motor nerve conduction velocity across the elbow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Second victims experience and support level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of participants with at least one exacerbation of asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serious adverse events reported
Endpoint domain: Adverse events/effects
Primary endpoint: Quality-adjusted life-year gain
Endpoint domain: Resource use
Primary endpoint: Withdrawal-like symptoms severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of associated symptoms during treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minor manifestations of LB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diabetes incidence in those with baseline prediabetes
Endpoint domain: Mortality/survival
Primary endpoint: rapport-building skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of hospital admission
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Prevalence of abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average rate of inopressors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative doses of inopressors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acid-base parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total repetitions performed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: volume load increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean power and velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in VAS (Visual Analog Scale) for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in non-compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes